Saturday, 26 August 2017

Food Therapy: Beet Juice, the Best Beverage for Reduced Risk and Treatment of Breast Cancer

Kyle J. Norton(Scholar, Master of Nutrients), all right reserved.
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.

In compared herbal medicine; food therapy even takes longer to ease symptoms of disease, depending to stage of the treatment which directly address to the cause.

Beet, one of the root vegetable may have a therapeutic effect in reduced risk and treatment of breast cancer, a renowned institute opinionated.

Beet,  a perennial plant with leafy stems growing to 1–2 m tall, is best known as the beetroot or garden beet, belongings to the amaranth family.

According to the Howard University, extract of red beetroot (Beta vulgaris L.), the FDA approved red food color E162, in animal model, exhibited anti cancer activity by suppressing the early onset of multi-organ tumors.

In the compared red beetroot extract and anticancer drug, doxorubicin cytotoxic effect against estrogen receptor-positive human breast cancer cells (MCF-7), both treated groups exerted a similar and significant anti breast cancer cell line effect in induction of cytotoxicity, although the cytotoxicity of the beetroot extract was significantly lower to those of doxorubicin.

Dr. Kapadia GJ, the lead author postulated, the breast cancer cell line inhibition of beetroot may be attributed to the phytochemical betanin, the major betacyanin constituent found abundantly in the vegetable.

Also in testing of chemotherapeutic drug oxorubicin (DOX, Adriamycin), at different concentrations of BRJ (0.5, 5, 50, 250, and 500 µg/ml) with or without DOX, BRJ showed a significantly reduced breast cancer cell growth within and at 48 hours, similar to those of DOX-induced apoptosis, observed by TUNEL assay.

Additionally, in dose dependent, co-treatment of BRJ and DOX, improved the efficacy of treatment in enhanced apoptosis in breast cancer cells by exerting a strong effect in ameliorated generation of reactive oxygen species (ROS by) produced by DOX.

In fact, lower concentrations, combination of BRJ and DOX, also displayed the most effective in explicited cardioprotection and chemoprevention in tested subjects synergistically.

More importantly, Dr. Kapadia GJ, the lead author in the other study conducted by the same University said, " a long-term daily exposure to low doses of B through diet might be safe and sufficient to produce cancer chemopreventive effect in humans.

Promisingly, intake of beet juice may also contribute to overall positive reduction in DOX drug concentration in use for influence cytotoxicitic activity for treatment of human breast cancer.

Taking together, Beet Juice, used alone or combination with chemotherapeutic medicine, may be served as a functional food for reduced risk and enhanced treatment of breast cancer.

(1) Cytotoxic effect of the red beetroot (Beta vulgaris L.) extract compared to doxorubicin (Adriamycin) in the human prostate (PC-3) and breast (MCF-7) cancercell lines by Kapadia GJ1, Azuine MA, Rao GS, Arai T, Iida A, Tokuda H.(PubMed)
(2) Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells by Das S1,2, Filippone SM1, Williams DS3, Das A1, Kukreja RC4,5.(PubMed)
(3) Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines by Kapadia GJ1, Rao GS, Ramachandran C, Iida A, Suzuki N, Tokuda H.(PubMed)

No comments:

Post a comment